Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Agreement among graders on Heidelberg retina tomograph (HRT) topographic change analysis (TCA) glaucoma progression interpretation.

Iester MM, Wollstein G, Bilonick RA, Xu J, Ishikawa H, Kagemann L, Schuman JS.

Br J Ophthalmol. 2015 Apr;99(4):519-23. doi: 10.1136/bjophthalmol-2014-305377. Epub 2014 Oct 21.

PMID:
25336573
2.

A case-crossover analysis of the impact of PM(2.5) on cardiovascular disease hospitalizations for selected CDC tracking states.

Talbott EO, Rager JR, Benson S, Brink LA, Bilonick RA, Wu C.

Environ Res. 2014 Oct;134:455-65. doi: 10.1016/j.envres.2014.06.018. Epub 2014 Sep 30.

PMID:
25277761
3.

In vivo three-dimensional characterization of the healthy human lamina cribrosa with adaptive optics spectral-domain optical coherence tomography.

Nadler Z, Wang B, Schuman JS, Ferguson RD, Patel A, Hammer DX, Bilonick RA, Ishikawa H, Kagemann L, Sigal IA, Wollstein G.

Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6459-66. doi: 10.1167/iovs.14-15177.

4.

Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3.

Sharifi-Sanjani M, Shoushtari AH, Quiroz M, Baust J, Sestito SF, Mosher M, Ross M, McTiernan CF, St Croix CM, Bilonick RA, Champion HC, Isenberg JS.

J Am Heart Assoc. 2014 Jun 10;3(3):e000670. doi: 10.1161/JAHA.113.000670.

5.

Reproducibility of in-vivo OCT measured three-dimensional human lamina cribrosa microarchitecture.

Wang B, Nevins JE, Nadler Z, Wollstein G, Ishikawa H, Bilonick RA, Kagemann L, Sigal IA, Grulkowski I, Liu JJ, Kraus M, Lu CD, Hornegger J, Fujimoto JG, Schuman JS.

PLoS One. 2014 Apr 18;9(4):e95526. doi: 10.1371/journal.pone.0095526. eCollection 2014.

6.

Gold nanorods as a contrast agent for Doppler optical coherence tomography.

Wang B, Kagemann L, Schuman JS, Ishikawa H, Bilonick RA, Ling Y, Sigal IA, Nadler Z, Francis A, Sandrian MG, Wollstein G.

PLoS One. 2014 Mar 3;9(3):e90690. doi: 10.1371/journal.pone.0090690. eCollection 2014.

7.

IOP elevation reduces Schlemm's canal cross-sectional area.

Kagemann L, Wang B, Wollstein G, Ishikawa H, Nevins JE, Nadler Z, Sigal IA, Bilonick RA, Schuman JS.

Invest Ophthalmol Vis Sci. 2014 Mar 25;55(3):1805-9. doi: 10.1167/iovs.13-13264.

8.

Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo.

Rauck BM, Friberg TR, Medina Mendez CA, Park D, Shah V, Bilonick RA, Wang Y.

Invest Ophthalmol Vis Sci. 2014 Jan 23;55(1):469-76. doi: 10.1167/iovs.13-13120.

9.

In vivo lamina cribrosa micro-architecture in healthy and glaucomatous eyes as assessed by optical coherence tomography.

Wang B, Nevins JE, Nadler Z, Wollstein G, Ishikawa H, Bilonick RA, Kagemann L, Sigal IA, Grulkowski I, Liu JJ, Kraus M, Lu CD, Hornegger J, Fujimoto JG, Schuman JS.

Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8270-4. doi: 10.1167/iovs.13-13109.

10.

Scaphoid translation measurements in normal wrists.

Wollstein R, Werner FW, Rubenstein R, Nacca CR, Bilonick RA, Gilula LA.

Hand Surg. 2013;18(2):179-87. doi: 10.1142/S0218810413500214.

PMID:
24164121
11.

Signal normalization reduces systematic measurement differences between spectral-domain optical coherence tomography devices.

Chen CL, Ishikawa H, Ling Y, Wollstein G, Bilonick RA, Xu J, Fujimoto JG, Sigal IA, Kagemann L, Schuman JS.

Invest Ophthalmol Vis Sci. 2013 Nov 5;54(12):7317-22. doi: 10.1167/iovs.13-12806.

PMID:
24114534
12.

Comparison of two methods for composite score generation in dry eye syndrome.

See C, Bilonick RA, Feuer W, Galor A.

Invest Ophthalmol Vis Sci. 2013 Sep 19;54(9):6280-6. doi: 10.1167/iovs.13-12150.

13.

Trends in acute myocardial infarction hospitalization rates for US States in the CDC tracking network.

Talbott EO, Rager JR, Brink LL, Benson SM, Bilonick RA, Wu WC, Han YY.

PLoS One. 2013 May 22;8(5):e64457. doi: 10.1371/journal.pone.0064457. Print 2013.

14.

The importance of early operative treatment in open fractures of the fingers.

Ng T, Unadkat J, Bilonick RA, Wollstein R.

Ann Plast Surg. 2014 Apr;72(4):408-10. doi: 10.1097/SAP.0b013e318264fcd5.

PMID:
23636111
15.

Individual A-scan signal normalization between two spectral domain optical coherence tomography devices.

Chen CL, Ishikawa H, Wollstein G, Ling Y, Bilonick RA, Kagemann L, Sigal IA, Schuman JS.

Invest Ophthalmol Vis Sci. 2013 May 17;54(5):3463-71. doi: 10.1167/iovs.12-11484.

16.

Three-dimensional spectral-domain optical coherence tomography data analysis for glaucoma detection.

Xu J, Ishikawa H, Wollstein G, Bilonick RA, Folio LS, Nadler Z, Kagemann L, Schuman JS.

PLoS One. 2013;8(2):e55476. doi: 10.1371/journal.pone.0055476. Epub 2013 Feb 11.

17.

High dynamic range imaging concept-based signal enhancement method reduced the optical coherence tomography measurement variability.

Ishikawa H, Chen CL, Wollstein G, Grimm JL, Ling Y, Bilonick RA, Sigal IA, Kagemann L, Schuman JS.

Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):836-41. doi: 10.1167/iovs.12-10990.

18.

Detection of glaucoma progression by population and individual derived variability criteria.

Folio LS, Wollstein G, Kotowski J, Bilonick RA, Ling Y, Ishikawa H, Kagemann L, Schuman JS.

Br J Ophthalmol. 2013 Apr;97(4):403-7. doi: 10.1136/bjophthalmol-2011-301028. Epub 2012 Nov 30.

19.

Inflammatory response to intravitreal injection of gold nanorods.

Gabriele Sandrian M, Wollstein G, Schuman JS, Bilonick RA, Ling Y, Ishikawa H, Kagemann L, McKenna KC.

Br J Ophthalmol. 2012 Dec;96(12):1522-9. doi: 10.1136/bjophthalmol-2012-301904. Epub 2012 Oct 19. Erratum in: Br J Ophthalmol. 2013 Jan.97(1):114.

20.

Glaucoma discrimination of segmented cirrus spectral domain optical coherence tomography (SD-OCT) macular scans.

Kotowski J, Folio LS, Wollstein G, Ishikawa H, Ling Y, Bilonick RA, Kagemann L, Schuman JS.

Br J Ophthalmol. 2012 Nov;96(11):1420-5. doi: 10.1136/bjophthalmol-2011-301021. Epub 2012 Aug 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk